The non-small cell lung cancer immune landscape: emerging complexity, prognostic relevance and prospective significance in the context of immunotherapy
Author:
Funder
Associazione Italiana per la Ricerca sul Cancro
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Link
http://link.springer.com/article/10.1007/s00262-018-2147-7/fulltext.html
Reference56 articles.
1. Malhotra J, Jabbour SK, Aisner J (2017) Current state of immunotherapy for non-small cell lung cancer. Transl Lung Cancer Res 6:196–211. https://doi.org/10.21037/tlcr.2017.03.01
2. Kim BJ, Kim JH, Kim HS (2017) Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: a meta-analysis and review. Oncotarget 8:51779–51785. https://doi.org/10.18632/oncotarget.17213
3. Tibaldi C, Lunghi A, Baldini E (2017) Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors. World J Clin Oncol 8:320–328. https://doi.org/10.5306/wjco.v8.i4.320
4. Wei SC, Levine JH, Cogdill AP et al (2017) Distinct cellular mechanisms underlie anti-CTLA-4 and anti-PD-1 checkpoint blockade. Cell 170:1120–1133. https://doi.org/10.1016/j.cell.2017.07.024
5. Tassi E, Grazia G, Vegetti C et al (2017) Early effector T lymphocytes coexpress multiple inhibitory receptors in primary non-small cell lung cancer. Cancer Res 77:851–861. https://doi.org/10.1158/0008-5472
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma;Journal of Cancer Research and Clinical Oncology;2024-04-11
2. Recurrence prediction of lung adenocarcinoma using an immune gene expression and clinical data trained and validated support vector machine classifier;Translational Lung Cancer Research;2023-10
3. Diagnostic value of [68Ga]Ga-Pentixafor versus [18F]FDG PET/CTs in non-small cell lung cancer: a head-to-head comparative study;Nuclear Medicine Communications;2023-06-12
4. Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response;Journal for ImmunoTherapy of Cancer;2022-08
5. APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b;Cellular and Molecular Life Sciences;2022-07-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3